Cetuximab sensitivity of head and neck squamous cell carcinoma xenografts is associated with treatment-induced reduction in EGFR, pEGFR, and pSrc-Reference-Cited by-同舟云学术

Cetuximab sensitivity of head and neck squamous cell carcinoma xenografts is associated with treatment-induced reduction in EGFR, pEGFR, and pSrc

Published:2017-01-28 Issue:9 Volume:46 Page:717-724
ISSN:0904-2512
Container-title:Journal of Oral Pathology & Medicine
language:en
Short-container-title:J Oral Pathol Med

Author:

Jedlinski Adam¹,Garvin Stina²,Johansson Ann-Charlotte³,Edqvist Per-Henrik⁴,Ponten Fredrik⁴,Roberg Karin¹³

Affiliation:

1. Department of ENT - Head and Neck Surgery; County Council of Östergötland; Linköping Sweden

2. Department of Clinical Pathology and Department of Clinical and Experimental Medicine; Linköping University; Linköping Sweden

3. Division of Oto-Rhino-Laryngology and Head and Neck Surgery; Department of Clinical and Experimental Medicine; Linköping University; Linköping Sweden

4. Department of Immunology, Genetics and Pathology and Science for Life Laboratory; Rudbeck Laboratory; Uppsala University; Uppsala Sweden

Funder

Åke Wiberg Stiftelse

Cancerfonden

Länsstyrelsen Östergötland

The Research Funds of Linköping University Hospital

The Foundation of Magn

The Cancer Foundation of Östergötland

Publisher

Wiley

Subject

Periodontics,Cancer Research,Otorhinolaryngology,Oral Surgery,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jop.12545/fullpdf

Reference23 articles.

1. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma;Ang;Cancer Res,2002

2. Epidermal growth factor-related peptides and their receptors in human malignancies;Salomon;Crit Rev Oncol Hematol,1995

3. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck;Bonner;N Engl J Med,2006

4. Effect of erlotinib on epidermal growth factor receptor and downstream signaling in oral cavity squamous cell carcinoma;Tsien;Head Neck,2013

5. EGFR status and EGFR ligand expression influence the treatment response of head and neck cancer cell lines;Jedlinski;J Oral Pathol Med,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance;Frontiers in Cell and Developmental Biology;2020-08-17

2. In�vitro measurement of glucose uptake after radiation and cetuximab treatment in head and neck cancer cell lines using 18F‑FDG, gamma spectrometry and PET/CT;Oncology Letters;2019-09-24

3. Cerium oxide nanoparticles with antioxidant capabilities and gadolinium integration for MRI contrast enhancement;Scientific Reports;2018-05-03

4. CD109 and squamous cell carcinoma;Journal of Translational Medicine;2018-04-06

5. Hypoxia Mediates Differential Response to Anti-EGFR Therapy in HNSCC Cells;International Journal of Molecular Sciences;2017-04-29